netFormulary
 Report : A-Z NHS England items in Formulary 26/10/2020 13:38:31
[Back]
 
Section Status NHS England Name
05.03.01 Formulary MHS England Abacavir 
05.03.01 Formulary MHS England Abacavir/lamivudine Kivexa
05.03.01 Formulary MHS England Abacavir/lamivudine/zidovudine Tizivir
08.02.04 Formulary MHS England Alemtuzumab 
10.02 Formulary MHS England Ataluren Translarna
05.03.01 Formulary MHS England Atazanavir 
05.03.01 Formulary MHS England Atazanavir sulfate/cobicistat Evotaz
08.01.05 Formulary MHS England Avelumab Bavencio
05.01.09 Formulary MHS England Bedaquiline Sirturo
05.03.01 Restricted Use MHS England Bictegravir / emtricitabine / tenofovir-alafenamide Biktarvy
09.08.01 Formulary MHS England Burosumab Crysvita
03.04.03 Formulary MHS England C1 esterase inhibitor Cinryze
03.04.03 Formulary MHS England C1 esterase inhibitor Berinert
04.08.01 Formulary MHS England Cannabidiol Epidyolex
10.02 Formulary MHS England Cladribine Mavenclad
05.03.01 Formulary MHS England Cobicistat Tybost
03.04.03 Formulary MHS England Conestat alfa Ruconest
05.03.01 Formulary MHS England Darunavir 
05.03.01 Formulary MHS England Darunavir/cobicistat Rezolsta
05.03.01 Formulary MHS England Darunavir/cobicistat/emtricitabine/tenofovir alafenamide fumarate  Symtuza
05.01.09 Formulary MHS England Delamanid Deltyba
08.01 Formulary MHS England Dexrazoxane Cardioxane
05.03.01 Formulary MHS England Didanosine 
05.03.01 Formulary MHS England Dolutegravir 
13.05.03 Formulary MHS England Dupilumab Dupixent) (dermatology
05.03.01 Formulary MHS England Efavirenz 
05.03.01 Formulary MHS England Efavirenz/emtricitabine/tenofovir disoproxil fumarate  Atripla
09.01 Restricted Use MHS England Efmoroctocog alfa Elocta
03.07 Restricted Use MHS England Elexacaftor/tezacaftor/ivacaftor Kaftrio
05.03.01 Formulary MHS England Elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide fumarate  Genvoya
05.03.01 Formulary MHS England Elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate Stribild
05.03.01 Formulary MHS England Emtricitabine 
05.03.01 Formulary MHS England Emtricitabine/rilpivirine/tenofovir alafenamide fumarate Odefsey
05.03.01 Formulary MHS England Emtricitabine/rilpivirine/tenofovir disoproxil fumarate Eviplera
05.03.01 Formulary MHS England Emtricitabine/tenofovir alafenamide fumarate Descovy
05.03.01 Formulary MHS England Emtricitabine/tenofovir disoproxil fumarate 
05.03.01 Formulary MHS England Etravirine 
05.03.01 Formulary MHS England Fosamprenavir 
03.04.03 Formulary MHS England Icatibant Firazyr
09.08.01 Formulary MHS England Inotersen Tegsedi
05.02.01 Formulary MHS England Isavuconazole Cresemba
03.07 Restricted Use MHS England Ivacaftor Kalydeco
05.03.01 Formulary MHS England Lamivudine 
05.03.01 Formulary MHS England Lamivudine/abacavir/dolutegravir Triumeq
05.01.12 Formulary MHS England Levofloxacin Quinsair
05.03.01 Formulary MHS England Lopinavir/ritonavir Kaletra
03.07 Restricted Use MHS England Lumacaftor/ivacaftor Orkambi
05.03.01 Formulary MHS England Maraviroc Celsentri
11.08 Non Formulary MHS England Mercaptamine (cysteamine)  Cystadrops
10.02.02 Formulary MHS England Mexiletine Namuscla
05.03.01 Formulary MHS England Nevirapine 
10.02 Formulary MHS England Nusinersen Spinraza
05.03.01 Formulary MHS England Raltegravir 
05.03 Formulary MHS England Remdesivir Veklury
05.03.01 Formulary MHS England Rilpivirine hydrochloride 
10.02 Formulary MHS England Risdiplam 
05.03.01 Formulary MHS England Ritonavir 
10.01.03 Formulary MHS England Rituximab/rituximab biosimilar MabThera, Rixathon, Truxima) (Rheumatology & Other
02.11 Formulary MHS England Rurioctocog alfa pegol Adynovi
05.03.01 Formulary MHS England Saquinavir 
05.03.01 Formulary MHS England Stavudine 
02.14 Formulary MHS England Tafamidis Vyndaqel
08.01.05 Formulary MHS England Temozolomide 
05.03.01 Formulary MHS England Tenofovir disoproxil fumarate 
03.07 Restricted Use MHS England Tezacaftor/ivacaftor Symkevi
09.08.01 Formulary MHS England Trientine  
02.11 Formulary MHS England Turoctocog alfa pegol Esperoct
09.01 Non Formulary MHS England Vonicog alfa Veyvondi
05.03.01 Formulary MHS England Zidovudine 
05.03.01 Formulary MHS England Zidovudine/lamivudine 
Southampton Joint Formulary